Macrophage lysosomal enzymes that have specificities for substrates found in mammalian tissue may contribute to the tissue damage observed in chronic inflammatory diseases. Although a variety of agents that stimulate the release of hydrolases from peritoneal macrophages have been identified, little work has been done to establish the conditions and specific stimuli responsible for enzyme release by alveolar macrophages (AM). To assess the effect of phagocytosis by AM on the release phenomenon, hydrolytic enzymes normally sequestered in AM lysosomes were quantified in the supernatant fluids of phagocytosing and nonphagocytosing AM monolayers in both the presence and absence of serum. Maximum release occurred under conditions known to favor complement fixation by the classical or alternative pathways. Thermal destruction or immune fixation of serum complement before use in culture reduced the magnitude of release to that observed in cultures incubated in the complete absence of serum. Phagocytosis was not essential for release, since cells exposed to particles but treated with a known inhibitor of phagocytosis (cytochalasin B) still showed maximal release in the presence of fresh serum. These data are interpreted to indicate that a heatlabile component of serum, probably a by-product of complement fixation, was primarily responsible for the hydrolase release by AM. On the basis of these findings, individuals suffering from chronic pulmonary disease may suffer acute episodes of lung destruction from endogenous AM enzymes upon the inhalation of materials capable of fixing complement.
Macrophage lysosomal enzymes that have specificities for substrates found in mammalian tissue may contribute to the tissue damage observed in chronic inflammatory diseases. Although a variety of agents that stimulate the release of hydrolases from peritoneal macrophages have been identified, little work has been done to establish the conditions and specific stimuli responsible for enzyme release by alveolar macrophages (AM). To assess the effect of phagocytosis by AM on the release phenomenon, hydrolytic enzymes normally sequestered in AM lysosomes were quantified in the supernatant fluids of phagocytosing and nonphagocytosing AM monolayers in both the presence and absence of serum. Maximum release occurred under conditions known to favor complement fixation by the classical or alternative pathways. Thermal destruction or immune fixation of serum complement before use in culture reduced the magnitude of release to that observed in cultures incubated in the complete absence of serum. Phagocytosis was not essential for release, since cells exposed to particles but treated with a known inhibitor of phagocytosis (cytochalasin B) still showed maximal release in the presence of fresh serum. These data are interpreted to indicate that a heatlabile component of serum, probably a by-product of complement fixation, was primarily responsible for the hydrolase release by AM. On the basis of these findings, individuals suffering from chronic pulmonary disease may suffer acute episodes of lung destruction from endogenous AM enzymes upon the inhalation of materials capable of fixing complement.
The purpose of this work was to establish some of the conditions that promote selective hydrolase release by alveolar macrophages (AM) and to compare our findings with those known for peritoneal macrophages (PM). The latter cells have been studied extensively in vitro with guinea pig or mouse cells. Several agents that promote the development of chronic inflammation in vivo induce PM to release hydrolytic enzymes in vitro. These include endotoxin (23) , lymphokines (24) , carrageenan (16) , and immune complexes (3) . The discovery that PM secrete collagenase (7, 23, 28) and elastase (7, 27) in vitro was particularly significant because it suggested that these cells may actively and continually promote host tissue destruction while remaining viable for long periods. The role that lung macrophages play in the amelioration or exacerbation of pulmonary disease is not clearly understood. Because of the different metabolic requirements (15) and hydrolase content (4, 9) of PM and AM, study of the latter cells is more pertinent for the investigation of the role of enzyme release in chronic pulmonary lesions. Only one study has been specifically designed to investigate hydrolase release by AM. Ackerman and Beebe demonstrated that guinea pig AM, after a 2-h incubation in vitro, released up to 26% of their /-glucuronidase while phagocytosing zymosan in the presence of autologous serum (1) . These authors did not investigate the effect of complement fixation on enzyme release.
The present study was designed to assess the effect of complement fixation on AM enzyme release under conditions that promote or suppress phagocytosis. Zymosan was used as one of the challenge particles because it is known to fix complement predominantly by the alternative pathway (8, 17 MATERIALS AND METHODS Culture of macrophages. New Zealand white rabbits were injected intravenously with 100 jig of heatkilled, lyophilized BCG in oil as previously described (21) . Alveolar macrophages were harvested from 3-to 5-week BCG-induced pulmonary granulomas by the savage technique of Myrvik et al. (14) . The cells were washed twice with Hanks balanced salt solution and standardized to 5 x 106 cells/ml. One-milliliter portions of this cell suspension were distributed to sterile siliconized tubes and centrifuged at 250 x g for 5 min at 250C. The supernatant fluids were removed, and the cells were resuspended in 2 12 .5 x 107/ml (0.25%). In experiments using S. typhimurium, the bacteria were cultivated in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) for 18 h, washed twice in sterile 0.15 M NaCl, autoclaved under standard conditions, and preserved in 0.3% formalin. Appropriate portions of the organisms were washed twice in sterile 0.15 M saline and once in medium before addition to the cultures. The final number of organisms per culture was 2.5 x 108.
Salmonella antiserum. Antiserum to Salmonella was prepared by intravenously injecting rabbits with the heat-killed organisms every other day for 18 days. After test bleeding, the animals were exsanguinated, and the antisera were collected and frozen at -70OC. The pooled antisera used in these experiments had an agglutination titer of 1,280. Pretreatment of reagents for culture. In some experiments, zymosan was used to pretreat serum or serum was used to pretreat zymosan before either was used in culture. In all cases, serum was collected from the animal from which AM would be taken for culture on that day. Serum was incubated with 0.25% zymosan particles at 37CC for 60 min. The zymosan and serum were separated by centrifugation (800 x g) and then resuspended and diluted (respectively) in medium for use in cultures. The treated zymosan particles were washed twice with medium before use in culture. In some experiments, serum was heated at 560C for 30 min to destroy complement. When Salmonella were used instead of zymosan, they were first incubated in heat-inactivated anti-Salmonella antiserum in the presence or absence of fresh autologous rabbit serum. A sheep erythrocyte-hemolysin indicator system (Baltimore Biological Laboratories, Cockeysville, Md.) was used to verify the complete depletion of native complement in fresh rabbit serum by Salmonella-antibody complexes, zymosan, and heat (2). Depletion of complement was considered complete when the indicator system showed no hemolysis in the presence of treated serum after incubation for 90 min at 370C.
Cobra venom factor (Cordis Laboratories, Miami, Fla.) was used to treat serum or was added simultaneously with serum to AM cultures. The cobra venom factor was diluted for use in medium or serum so that the final concentration in the culture was 0.2 U/ml.
Enzyme and protein assays. fl-Glucuronidase was assayed by the method of Talalay et al. (22) (6) .
RESULTS
During preliminary experiments, it was observed that variations in pH markedly affected enzyme release and viability. To test this possibility, AM were incubated in 0.1 M PBS at varying pH values for 2 h, and protein and enzyme activities were assayed in the supernatant fluids (Fig. 1) . Viability as measured by both methods (Fig. 1A) remained high up to pH 7.6, where it began to drop. At the higher pH values, the lactic acid dehydrogenase release was not as severe as the uptake of trypan blue. The release of /3-glucuronidase and N-acetyl-fl-glucosaminidase was most evident at the extremes of pH (Fig. 1B) , and selective hydrolase release, as indicated by the specific activities of the enzymes (Fig. 1C) Since the process of enzyme release occurred more slowly in our system than that reported for guinea pig AM (1), we followed the time-course release of 83-glucuronidase over a 24-h period. In separate experiments, different numbers of zymosan particles were added to cultures to determine the maximal number that should be used for enzyme release studies (Fig. 2) . Control cultures of 5 x 106 macrophages released less than 5% of their 8)-glucuronidase over a 24-h period, whereas cultures phagocytosing zymosan in the presence of fresh autologous serum released more than 25% of their enzymes in the same period. This phenomenon was dependent upon the amount of zymosan in the cultures (inset, Fig. 2) , wherein a maximum release was approached at a zymosan concentration of 1.25 X 108 particles/ml.
The time-course experiments reported in Fig.  2 involved cultures exposed to 10% fresh autologous serum. To determine the effect of serum on enzyme release by AM, cultures were incubated for 24 h in the complete absence of serum or in the presence of fresh or heated autologous serum. The results for cultures in the presence or absence of zymosan under these three conditions are depicted in Fig. 3 . The absence of serum inhibited the release of the enzymes in the 24-h incubation period regardless of the presence of zymosan, although phagocytosing cultures did release a modest but significant (Fig. 3 and 4) . , 8- Glucuronidase and N-acetyl-f)-glucosaminidase were the most invariable hydrolases measured. Elastase was not detectable in any of the conditions imposed. If AM elastase was inactivated by serum, the supernatant fluids from cultures incubated in the complete absence of serum were repeatedly assayed. Lysozyme release was monitored under all experimental conditions, but its release due to phagocytosis and serum factors was incalculable because of the varying rates of synthesis and secretion of the enzyme between cell preparations. Nevertheless, within an experiment lysozyme release was always greater when fresh serum and zymosan were present in the cultures.
Since zymosan and serum were both required for maximal enzyme release (Fig. 3) , it was essential to determine whether this stimulus was peculiar to zymosan alone. To test this possibility, AM were incubated under the same conditions used for the zymosan experiments except that the particles phagocytosed were heat-killed, formalinized S. typhimurium. The Salmonella were added to cultures in the absence of any serum, in the presence of a heat-inactivated autologous serum or isologous antiserum, in the presence of fresh serum, or in the presence of both antibody and fresh serum. The cultures in which the highest fl-glucuronidase release occurred contained Salmonella, antiserum, and fresh serum (Fig. 4) .
To determine whether the. responsible serum components) remained free in the serum or bound to the particles, we incubated control and test cultures with serum that had been "depleted" by zymosan or Salmonella-antibody complexes. Conversely, some cultures were incubated in the presence of zymosan that had been pretreated with serum, but with no fresh serum in the culture medium. The results listed in Table 1 by its incubation in serum, and release with the treated zymosan even in the absence of serum was comparable to that noted in the previously described experiments. The data in Table 2 represent results for the serum-treated Salmonellaantibody complexes, untreated complexes, and complex-treated serum. As with the zymosan system, a serum factor bound to the complexes and promoted the release of 8-glucuronidase. In all of the experiments described, the accumulation of /8-glucuronidase and N-acetyl-,8-glucosaminidase in the medium was accompanied by a concomitant loss of these enzymes in the cell sheets, indicating that preformed enzymes, and not molecules synthesized de novo, were being released.
The heat treatment of serum destroyed complement and reduced the release of enzymes, suggesting that the serum factor involved was indeed one of the by-products of complement fixation. 'The Salmonella used as the particle in these experiments were sensitized with heat-inactivated Salmonella-specific antiserum and then washed twice before use. serum would induce release by itself (25) . In our experiments, zymosan-treated serum used in zymosan-free cultures did not stimulate release; however, both C3b and C5a are inactivated by serum enzymes (13) , and these by-products of complement fixation may have been hydrolyzed during the serum treatment period. In addition, cobra venom factor generates C3b in serum (13) , but unless this molecule was bound to a particle or complex in our experiments, they were most likely inactivated. Several lines of evidence implicate C3b as the responsible molecule. Zymosan is known to bind the activated components of C3 (8) and, in our system, serum-treated zymosan stimulated release even when AM were not exposed to any serum (Table 1) . Schorlemmer and Allison (19) showed that purified C3b, but not native C3, caused enzyme release from mouse PM in the absence of any endocytosis. Coupled with the demonstrations of receptors for C3b on guinea pig (26) , human, and rabbit AM (18) , it is reasonable to suggest that C3b or other by-products of complement fixation were responsible for the stimulation of release seen in our experiments when complement was fixed by zymosan or Salmonella-antibody complexes. Experiments in progress are designed to test this hypothesis.
Cytochalasin B was used in this study to eliminate the possibility that increased phagocytosis due to the generation of opsonins was solely responsible for increased enzyme release when fresh serum and particles were present. We attempted to determine whether phagocytosis was more intense in cultures containing serum and zymosan than those containing zymosan alone by performing intracellular particle counts. Because the cells were so engorged with particles at 24 h in both culture systems, we could not rule out this possibility. Nevertheless, phagocytosis of zymosan was markedly inhibited by cytochalasin B and, although the particles were bound to the cells, they were not ingested. Enzyme release was highest under these conditions (Fig. 3) .
The observations on the effects of pH on both the viability and hydrolase release of rabbit AM (Fig. 1) are pertinent to many experiments in which these cells are maintained in vitro even for short periods. Although the cells remained viable at pH values below 6.6, the enzyme release was sufficient to indicate perturbation of the cells. A potential problem in the culture of AM is the toxic effect of alkaline medium, considering the common practice of using slightly alkaline medium at the initiation of culture. In our system, viability began to decrease at pH 7.6 in PBS. Exposure of medium to air and the addi-tion of serum and other supplements can make the initial pH of medium unsuitable for maintenance of viable cells. Indeed, Debanne et al. (5) showed that the uptake of proteinase-a-macroglobulin complexes by rabbit AM was inhibited below pH 6.5 and optimal between 7.0 and 7.5.
It is interesting to note in Fig. 1C that the release of /B-glucuronidase and N-acetyl-,/-glucosaminidase paralleled in acid pH but differed substantially in alkaline pH. These data suggest that acid pH may stimulate selective release of these hydrolases from viable cells, but that alkaline pH upon killing the cells causes an unregulated release, the pattern of which would reflect differences in cell localization and sequestration of the enzymes. We searched for elastase activity in both supernatant fluids and cell pellets under all of the experimental conditions imposed, and although the technique used was sufficiently sensitive to detect less than 1.0 ,tg of elastase per ml, no activity was observed. Elastin was used as the substrate because Levine et al. (10) demonstrated that unstimulated, freshly harvested rabbit AM had activity when synthetic substrates were used, but had no activity when the same samples were assayed with elastin. The activity observed with synthetic substrates may have reflected neutral protease activity. Werb and Gordon reported weak activity in cultured BCGinduced AM (27) 24 h, our data and those of other authors (10, 27) are incongruent with this report. The role of elastase in lung disease and its generation by AM therefore remain unresolved.
